What's new

EMEA-003025-PIP03-23-M01

EMEA-003025-PIP03-23-M01

Feb 13, 2025 - 15:48
 0
EMEA-003025-PIP03-23-M01
EMEA-003025-PIP03-23-M01
Read More

Tags:

Previous Article

Fierce Biotech Fundraising Tracker '25: Newleos emerges with $93M; Abcuro raises...

Next Article

Carrier unveils data center strategy, growth in Q4 HVAC sales

Related Posts

Human medicines European public assessment report (EPAR): Erbitux, cetuximab, Date of authorisation: 29/06/2004, Revision: 33, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 19, 2025  0

Human medicines European public assessment report (EPAR): Comirnaty, COVID-19 mRNA vaccine,tozinameran,riltozinameran and tozinameran,famtozinameran and tozinameran,raxtozinameran, Date of authorisation: 21/12/2020, Revision: 52, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 27, 2025  0

Herbal medicinal product: Pilosellae herba cum radiceArray, F: Assessment finalised

Herbal medicinal product: Pilosellae herba cum radiceAr...

Feb 26, 2025  0